SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006130
Filing Date
2015-08-05
Accepted
2015-08-05 06:04:42
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20150630.htm 10-Q 3899572
2 EX-31 bmrn-ex31_6.htm EX-31 12591
3 EX-31.2 bmrn-ex31_7.htm EX-31 12661
4 EX-32.1 bmrn-ex32_8.htm EX-32 5596
  Complete submission text file 0001564590-15-006130.txt   16751132

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20150630.xml EX-101.INS 5077714
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20150630.xsd EX-101.SCH 64955
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20150630_cal.xml EX-101.CAL 103358
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20150630_def.xml EX-101.DEF 240911
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20150630_lab.xml EX-101.LAB 524723
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20150630_pre.xml EX-101.PRE 449905
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 151027377
SIC: 2834 Pharmaceutical Preparations